# Semnur Pharmaceuticals, Inc.: Form 8-K, filed Apr 23, 2026

- Company: [Semnur Pharmaceuticals, Inc.](/companies/smnr.md) (CIK 1913577)
- Form: 8-K
- Filed: 2026-04-23
- Accepted by EDGAR: Apr 23, 2026, 16:08 ET
- Period: 2026-04-20
- Accession: 0001193125-26-173690
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1913577/000119312526173690/smnr-20260420.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1913577/000119312526173690/

## Items reported

- Item 1.02: Termination of a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1913577/000119312526173690/smnr-20260420.htm

Filed Apr 23, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-173690. Last ingested by Listed: Nov 4, 2026, 17:17 ET. No prices; not investment advice.
